2nd Quarter - Report
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 2207: Protect Medical Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Regulatory and legislative proposals in the Administrations Blueprint. H.R.2113: Prescription Drug STAR Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Promoted life sciences community and communicated economic and health benefits of the industry. H.R 269: Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.